荧光材料增强契伦科夫光学信号的探索研究

郑盛; 屈亚威; 查佳丽; 谭灵姗; 刘海峰

doi:10.16016/j.1000-5404.201709064

您当前的位置：

首页 >

文章列表页 >

荧光材料增强契伦科夫光学信号的探索研究

基础医学 | 更新时间：2026-01-09

- 荧光材料增强契伦科夫光学信号的探索研究
- Enhanced Cerenkov luminescence imaging in vitro and in tumor-bearing mice using tetracycline, fluorescein isothiocyanate, and fluorescein sodium
- 第三军医大学学报 2017年39卷第22期页码：2182-2188
- 作者机构：
  
  100039 北京，武警总医院消化内科
- 作者简介：
  
  [ 刘海峰, 电话: (010)57976101, E-mail: haifengliu333@163.com LIU Haifeng, Tel: (010)57976101, E-mail: haifengliu333@163.com
- 基金信息：
  
  国家自然科学基金面上项目(81471700)
- DOI：10.16016/j.1000-5404.201709064
  中图分类号： R312;R817.4;R981.1
- 收稿：2017-09-10，
  
  修回：2017-09-20，
  
  纸质出版：2017-11-30
- 稿件说明：
移动端阅览
郑盛, 屈亚威, 查佳丽, 等. 荧光材料增强契伦科夫光学信号的探索研究[J]. 第三军医大学学报, 2017,39(22):2182-2188.

Sheng ZHENG, Yawei QU, Jiali ZHA, et al. Enhanced Cerenkov luminescence imaging in vitro and in tumor-bearing mice using tetracycline, fluorescein isothiocyanate, and fluorescein sodium[J]. Journal of Third Military Medical University, 2017, 39(22): 2182-2188.
郑盛, 屈亚威, 查佳丽, 等. 荧光材料增强契伦科夫光学信号的探索研究[J]. 第三军医大学学报, 2017,39(22):2182-2188. DOI： 10.16016/j.1000-5404.201709064.

Sheng ZHENG, Yawei QU, Jiali ZHA, et al. Enhanced Cerenkov luminescence imaging in vitro and in tumor-bearing mice using tetracycline, fluorescein isothiocyanate, and fluorescein sodium[J]. Journal of Third Military Medical University, 2017, 39(22): 2182-2188. DOI： 10.16016/j.1000-5404.201709064.

摘要

目的

探究四环素、荧光素钠、异硫氰酸荧光素(fluorescein isothiocyanate，FITC)这3种临床可用的荧光材料对契伦科夫光学信号增强的效果及最佳应用方案。

方法

将不同浓度的四环素溶液(100、50、10、5、1、0.5、0.1、0.05、0.01 mmol/L)、FITC溶液(5、4、3、2.5、1.5、1、0.5、0.25 mmol/L)和荧光素钠溶液(100、50、10、5、2、1、0.2、0.1 mmol/L)分别与100 μCi的

F-FDG混合后进行契伦科夫光学成像(Cerenkov luminescence imaging，CLI)，观察契伦科夫光学信号的增强效果，并勾画感兴趣区域(region of interest，ROI)，对光学信号强度进行定量分析，确定最佳信号增强效果的浓度，并对信号最强的板孔以20 nm为间隔进行500~800 nm范围的光谱分离成像。同时进行在体实验验证荧光素钠及FITC对契伦科夫光的增强效果。

结果

不同浓度的四环素溶液对光学信号无明显影响。FITC及荧光素钠均能显著提高契伦科夫光学信号强度。当FITC及荧光素钠浓度分别为1或2 mmol/L时产生的光学信号强度最强，为单独的

F-FDG的3.2倍及5倍。光谱分析表明2 mmol/L的荧光素钠能将

F-FDG产生的契伦科夫光(cerenkov luminescence，CL)光红移至540 nm附近。荷瘤鼠在体实验表明注射FITC或荧光素钠后能使肿瘤部位的CL信号强度提高2倍或3.9倍。

结论

FITC、荧光素钠均能通过契伦科夫光的激发效应来增强契伦科夫光学信号强度，提高组织穿透力。

Abstract

Objective

To compare the performance of 3 clinically available fluorescent materials

namely tetracycline

fluorescein sodium

and fluorescein isothiocyanate (FITC)

in enhancing Cerenkov luminescence imaging (CLI) signal and determine the best strategy for enhanced CLI.

Methods

In vitro

CLI was performed using

F-FDG (100 μCi) mixed with different concentrations of tetracycline (100

0.5

0.1

0.05

and 0.01 mmol/L)

fluorescein sodium (5

2.5

1.5

0.5

and 0.25 mmol/L)

or FITC (100

0.2

and 0.1 mmol/L)

and the enhancement of Cerenkov radiance (CR) intensity was assessed. The optical signal intensity was quantified by region of interest (ROI) analysis to determine the optimal concentration of the agents for signal enhancement. The emission spectra from the wells with the strongest signals were analyzed at a 20-nm interval within the spectrum range of 500 to 800 nm. The effects of fluorescein sodium and FITC in enhancing CR intensity were also verified by

in vivo

imaging in a tumor-bearing nude mouse model.

Results

The results of

in vitro

CLI showed that tetracycline failed to enhance the CR of

F-FDG

while both fluorescein sodium and FITC significantly enhanced the intensity of Cerenkov signals. Fluorescein sodium at 2 mmol/L and FITC at 1 mmol/L resulted in the strongest enhancement of CR intensity by 3.2 and 5 folds

respectively. Spectrum analysis confirmed that fluorescein sodium caused a red shift of Cerenkov spectrum peak to 540 nm.

In vivo

CLI of the tumor-bearing mice showed that injection of fluorescein sodium and FITC increased the CR intensity at the tumor site by 3.9 and 2 folds

respectively.

Conclusion

FITC and fluorescein sodium can both enhance the optical signal intensity and improve the tissue penetration of CLI by excitation of CR.

关键词

Keywords

references

THOREK D L, ROBERTSON R, BACCHUS W A, et al . Cerenkov imaging -a new modality for molecular imaging[J ] . Am J Nucl Med Mol Imaging, 2012, 2(2): 163-173.

XU Y, LIU H, CHENG Z. Harnessing the power of radio-nuclides for optical imaging: Cerenkov luminescence imaging[J]. J Nucl Med, 2011, 52(12): 2009-2018. DOI: 10.2967/jnumed.111.092965.

XU Y, CHANG E, LIU H, et al . Proof-of-concept study of monitoring cancer drug therapy with cerenkov luminescence imaging[J ] . J Nucl Med, 2012, 53(2): 312-317. DOI: 10.2967/jnumed.111.094623.

马晓伟, 杨卫东, 汪静.切伦科夫光学成像研究进展[J].中华核医学与分子影像杂志, 2012, 32(1): 72-74. DOI: 10.3760/cma.j.issn.2095-2848.2012.01.024.

MA X W, YANG W D, WANG J. Progress in cerenkov luminescence imaging[J]. Chin J Nucl Med Mol Imaging, 2012, 32(1): 72-74. DOI: 10.3760/cma.j.issn.2095-2848.2012.01.024.

THOREK D L, DAS S, GRIMM J. Molecular imaging using nanoparticle quenchers of Cerenkov luminescence[J]. Small, 2014, 10(18): 3729-3734. DOI: 10.1002/smll.201400733.

GROOTENDORST M R, CARIATI M, PINDER S E, et al . Intraoperative assessment of tumor resection margins in breast-conserving surgery using 18 F-FDG cerenkov luminescence imaging: a first-in-human feasibility study[J ] . J Nucl Med, 2017, 58(6): 891-898. DOI: 10.2967/jnumed.116.181032..

LEE S B, YOON G, LEE S W, et al . Combined positron emission tomography and cerenkov luminescence imaging of sentinel lymph nodes using PEGylated radionuclide-embedded gold nanoparticles[J ] . Small, 2016, 12(35): 4894-4901. DOI: 10.1002/smll.20160 1721.

HU H, CAO X, KANG F, et al . Feasibility study of novel endoscopic cerenkov luminescence imaging system in detecting and quantifying gastrointestinal disease: first human results[J ] . European Radiology, 2015, 25(6): 1814-1822. DOI: 10.1007/s00330-014-3574-2.

HU Z, QU Y, WANG K, et al . In vivo nanoparticle-mediated radiopharmaceutical-excited fluorescence molecular imaging[J ] . Nature Communications, 2015, 6: 7560. DOI: 10.1038/ncomms8560..

BOSCHI F, CALDERAN L, D'AMBROSIO D, et al . In vivo 18 F-FDG tumour uptake measurements in small animals using cerenkov radiation[J ] . Eur J Nucl Med Mol Imaging, 2011, 38(1): 120-127. DOI: 10.1007/s00259-010-1630-y..

THOREK D L, RIEDL C C, GRIMM J. Clinical cerenkov luminescence imaging of 18 F-FDG[J ] . J Nucl Med, 2014, 55(1): 95-98. DOI: 10.2967/jnumed.113.127266.

CHIN P T, WELLING M M, MESKERS S C, et al . Optical imaging as an expansion of nuclear medicine: cerenkov-based luminescence vs fluorescence-based luminescence[J ] . Eur J Nucl Med Mol Imaging, 2013, 40(8): 1283-1291. DOI: 10.1007/s00259-013-2408-9.

何耘, 屈亚威, 宋天明, 等.荧光素钠在切伦科夫能量转移中的应用[J].中华核医学与分子影像杂志, 2015, 35(1): 59-62. DOI: 10.3760/cma.j.issn.2095-2848.2015.01.014.

HE Y, QU Y W, SONG T M, et al . Application of fluorescein sodium on cerenkov radiation energy transfer[J ] . Chin J Nucl Med Mol Imaging, 2015, 35(1): 59-62. DOI: 10.3760/cma.j.issn. 2095-2848. 2015.01.014.

DOTHAGER R S, GOIFFON R J, JACKSON E, et al . Cerenkov radiation energy transfer (CRET) imaging: a novel method for optical imaging of PET isotopes in biological systems[J ] . PLoS ONE, 2010, 5(10): e13300. DOI: 10.1371/journal.pone.0013300.

THOREK D L, OGIRALA A, BEATTIE B J, et al . Quantitative imaging of disease signatures through radioactive decay signal conversion[J ] . Nat Med, 2013, 19(10): 1345-1350. DOI: 10.1038/nm.3323.

SHAFFER T M, PRATT E C, GRIMM J. Utilizing the power of cerenkov light with nanotechnology[J]. Nat Nanotechnol, 2017, 12(2): 106-117. DOI: 10.1038/nnano.2016.301.

MA X, KANG F, XU F, et al . Enhancement of cer enkov luminescence imaging by dual excitation of Er3+, Yb3+-doped rare-earth microparticles[J ] . PLoS ONE, 2013, 8(10): e77926. DOI: 10.1371/journal.pone.0077926.

玄光善, 孙红梅, 吴效楠, 等.荧光光谱法研究四环素和牛血清蛋白的荧光猝灭和增敏作用[J].光谱实验室, 2006, 23(6): 1318-1322. DOI: 10.3969/j.issn.1004-8138.2006.06. 051.

XUAN G S, SHUN H M, WU X N, et al . The fluorescence quenching and sensitizing interaction between tetracycline and bovine serum albumin by fluorescence spectroscopy[J ] . Chin J Spectrosc Lab, 2006, 23(6): 1318-1322. DOI: 10.3969/j.issn.1004-8138.2006.06.051.

聂松.四环素亲癌现象研究及耳血四环素荧光实验在胃癌普查中的应用[J].北京医学, 1979, 1(2): 102-105, 130. DOI: 10.15932/j.0253-9713.1979.02.015.

NIE S. The study of tetracycline affinity for cancer tissue and application of gastric cancer mass screening by tetracycline test with ear-puncture blood[J]. Beijing Med J, 1979, 1(2): 102-105, 130. DOI: 10.15932/j.0253-9713.1979.02.015.

GUDURU A, MARTZ T G, WATERS A, et al . Oxygen saturation of retinal vessels in all stages of diabetic retinopathy and correlation to ultra-wide field fluorescein angiography[J ] . Invest Ophthalmol Vis Sci, 2016, 57(13): 5278-5284. DOI: 10.1167/iovs.16-20190.

ZHANG Y L, BAI L, LI Z, et al . A lower dose of fluorescein sodium is more suitable for confocal laser endomicroscopy: a feasibility study[J ] . Gastrointest Endosc, 2016, 84(6): 917-923.e5. DOI: 10.1016/j.gie.2016.05.011.

连喜军, 鲁晓翔, 刘勤生, 等.荧光素钠法测定β-葡聚糖含量的研究[J].食品研究与开发, 2006, 27(10): 116-119. DOI: 10.3969/j.issn.1005-6521.2006.10.039.

LIAN X J, LU X X, LIU Q S, et al . The study on determination of Β-GLucan by fluorimetry with sodium fluorescein[J ] . Food Res Dev, 2006, 27(10): 116-119. DOI: 10.3969/j.issn.1005-6521.2006.10. 039.

VAN DAM G M, THEMELIS G, CRANE L M, et al . Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results[J ] . Nat Med, 2011, 17(10): 1315-1319. DOI: 10.1038/nm.2472.

CONTI P S, LILIEN D L, HAWLEY K, et al . PET and 18 F-FDG in oncology: a clinical update[J ] . Nucl Med Biol, 1996, 23(6): 717-735. DOI: 10.1016/0969-8051(96)00074-1..

何诚.实验动物学[M].北京:中国农业大学出版社, 2005: 67-81.

HE C. Laboratory animal science[M]. Beijing: China Agricultural University Press, 2005: 67-81.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

应用FITC系统建立非均衡竞争游离三碘甲腺原氨酸(FT₃)化学发光法

纳米细菌致Ⅲ型前列腺炎的实验研究

应用四环素经纤维支气管镜行微创肺减容术的动物实验研究